Decreased Susceptibility to Macrolide-Lincosamide in Mycoplasma synoviae Is Associated with Mutations in 23S Ribosomal RNA.
The mechanism responsible for acquired decreased susceptibility to macrolides (14-membered erythromycin [Ery], 16-membered tylosin [Ty] and tilmicosin [Tm]) and to lincosamides (lincomycin [Ln]) was investigated in Mycoplasma synoviae, a pathogen that causes respiratory infections and synovitis in chicken and turkey. Sequence analysis of domains II and V of the two 23S rRNA alleles and ribosomal proteins L4 and L22 was performed on 49 M. synoviae isolates, M. synoviae type strain WVU1853, and reference strain FMT showing minimal inhibitory concentrations (MICs) to Ty (≤ 0.015 to 2 μg/ml), Tm (0.03 to ≥ 8 μg/ml), and Ln (0.125 to 8 μg/ml); MICs to Ery ranged from 32 to ≥ 128 μg/ml. Our results showed that the nucleotide substitution G748A (Escherichia coli numbering) in domain II of one or both 23S rRNA alleles may account for a slight increase in MICs to Ty and Tm (up to 0.5 and 2 μg/ml, respectively). No correlation between the presence of G748A and decreased susceptibility to Ln was found. However, the presence of the point mutations A2058G or A2059G in domain V of one or both alleles of the 23S rRNAs was correlated with a more significant decrease in susceptibility to Ty (1-2 μg/ml), Tm (≥ 8 μg/ml), and Ln (≥ 8 μg/ml). All M. synoviae isolates tested had a G2057A transition in the 23S rRNAs consistent with previously described intrinsic resistance to Ery. Mutations G64E (one isolate) and Q90K/H (two isolates) were identified in the L4 and L22 proteins, respectively, but their impact on decreased susceptibility to macrolides and lincomycin was not clear.
1 Mycoplasma Unit, Division of Avian and Aquatic Diseases, Kimron Veterinary Institute , Beit Dagan, Israel .
Inna
I
Lysnyansky
1 Mycoplasma Unit, Division of Avian and Aquatic Diseases, Kimron Veterinary Institute , Beit Dagan, Israel .
Irena
I
Gerchman
2 Mycoplasma Unit, Avian Medicine Laboratory, Istituto Zooprofilattico Sperimentale delle Venezie , Padova, Italy .
Barbara
B
Flaminio
2 Mycoplasma Unit, Avian Medicine Laboratory, Istituto Zooprofilattico Sperimentale delle Venezie , Padova, Italy .
Salvatore
S
Catania
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001426:Bacterial Proteins / Q000235:genetics; D002645:Chickens / Q000382:microbiology*; D004917:Erythromycin / Q000494:pharmacology; D015870:Gene Expression; D008034:Lincomycin / Q000494:pharmacology; D008826:Microbial Sensitivity Tests; D009175:Mycoplasma Infections / Q000188:drug therapy / Q000382:microbiology / Q000662:veterinary*; D045805:Mycoplasma synoviae / Q000187:drug effects* / Q000235:genetics / Q000254:growth & development; D017354:Point Mutation; D011201:Poultry Diseases / Q000188:drug therapy* / Q000382:microbiology; D012338:RNA, Ribosomal, 23S / Q000235:genetics*; D012269:Ribosomal Proteins / Q000235:genetics; D014422:Turkeys / Q000382:microbiology*; D015645:Tylosin / Q000031:analogs & derivatives / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; D012338:RNA, Ribosomal, 23S; D012269:Ribosomal Proteins; D004917:Erythromycin; D008034:Lincomycin; C052319:tilmicosin; D015645:Tylosin